focus -WSS

focus

author：comprehensive 2025-10-01 15:31:55 - browse：137

Adam's take main illustration — Molly Ferguson/STAT

This week, an encouraging turnaround for Ocular Therapeutix, a chat with Alnylam’s CEO defending changes to the HELIOS-B study and talking up its hypertension treatment, and quick takes on Amylyx and obesity stocks.

A Worst CEO gets some much-needed help

For most of last year, Ocular Therapeutix CEO Antony Mattessich promised shareholders that he was close to nailing down a lucrative pharma partnership that would pay for late-stage clinical trials of the company’s treatments for degenerative eye diseases. The deal never happened. I heard from many Ocular investors who were frustrated and angry about Mattesich’s poor job performance. He ended up earning a spot last year on my worst biopharma CEO list. It was an easy pick.

On Thursday, Ocular announced a meaningful “leadership update.” Mattessich is still the CEO, but let’s just say the company’s board decided to surround him with new executives and retinal experts with proven track records of getting stuff done.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： What happened to the House vote on health price transparency?

WSS

People with substance use disorder deserve online privacy

How the messy conversation about Dolly changed bioethics

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

How the messy conversation about Dolly changed bioethics

Bankrupt Pear's prescription app helped MassHealth save money, data suggests

Grad students accuse University of California of wage theft

hotspot

focus

A Worst CEO gets some much-needed help

focus

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Trump demands the U.S. pay no more for drugs than other countries … again

California man arrested in connection with serial murders of Mexican strip club workers

Hollywood unions extend contract negotiations for actors

White House Covid adviser calls on docs to combat misinformation

Medicare details structure of new drug price negotiation program

Drinking water from half of US faucets contains PFAS: Study

entertainment

What happened to the House vote on health price transparency?

The PBM ad wars are taking over Washington, D.C.

PBMs drew scrutiny in House hearing — and so did pharma

House panel to mark up pandemic

US intelligence assessment says Iran not currently developing nuclear weapons

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

focus

focus

Wikipedia

entertainment